| Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. | |
| | |
MedLine Citation:
|
PMID: 19762705 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND PURPOSE: Microbleeds (MBs) are commonly observed in Alzheimer disease. A minority of patients has multiple MBs. We aimed to investigate associations of multiple MBs in Alzheimer disease with clinical and MRI characteristics and cerebrospinal fluid biomarkers. METHODS: Patients with Alzheimer disease with multiple (>or=8) MBs on T2*-weighted MRI were matched for age, sex, and field strength with patients with Alzheimer disease without MBs on a 1:2 basis. We included 21 patients with multiple MBs (73+/-7 years, 33% female) and 42 patients without MBs (72+/-7 years, 38% female). Mini-Mental State Examination was used to assess dementia severity. Cognitive functions were assessed using neuropsychological tests. Medial temporal lobe atrophy (0 to 4), global cortical atrophy (0 to 3), and white matter hyperintensities (0 to 30) were assessed using visual rating scales. In a subset, apolipoprotein E genotype and cerebrospinal fluid amyloid beta 1-42, total tau and tau phosphorylated at threonine 181 were determined. RESULTS: Patients with multiple MBs performed worse on Mini-Mental State Examination (multiple MB: 17+/-7; no MB: 22+/-4, P<0.05) despite similar disease duration. Atrophy was not related to presence of MBs, but patients with multiple MBs had more white matter hyperintensities (multiple MB: 8.8+/-4.8; no MB: 3.2+/-3.6, P<0.05). Adjusted for age, sex, white matter hyperintensities, and medial temporal lobe atrophy, the multiple MB group additionally performed worse on Visual Association Test object naming and animal fluency. Patients with multiple MBs had lower cerebrospinal fluid amyloid beta 1-42 levels (307+/-61) than patients without MBs (505+/-201, P<0.05). Adjusted for the same covariates, total tau, and tau phosphorylated at threonine 181 were higher in the multiple MB group. CONCLUSIONS: Microbleeds are associated with the clinical manifestation and biochemical hallmarks of Alzheimer disease, suggesting possible involvement of MBs in the pathogenesis of Alzheimer disease. |
| | |
Authors:
|
Jeroen D C Goos; M I Kester; Frederik Barkhof; Martin Klein; Marinus A Blankenstein; Philip Scheltens; Wiesje M van der Flier |
Related Documents
:
|
12163905 - Snakebites by crotalus durissus ssp in children in campinas, são paulo, brazil. 20883485 - Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/c... 15694805 - Peri-operative myocardial injury in patients undergoing surgery for critical limb ischa... 9383485 - Evaluation of a bedside whole-blood rapid troponin t assay in the emergency department.... 4031955 - The causes of stroke in the young. 17617295 - Heart failure patients' awareness and perceptions of the risk of using nsaids: a pilot ... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't Date: 2009-09-17 |
Journal Detail:
|
Title: Stroke; a journal of cerebral circulation Volume: 40 ISSN: 1524-4628 ISO Abbreviation: Stroke Publication Date: 2009 Nov |
Date Detail:
|
Created Date: 2009-10-27 Completed Date: 2009-11-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0235266 Medline TA: Stroke Country: United States |
Other Details:
|
Languages: eng Pagination: 3455-60 Citation Subset: IM |
Affiliation:
|
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands. j.goos@vumc.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Alzheimer Disease / cerebrospinal fluid*, complications, psychology Biological Markers / cerebrospinal fluid Case-Control Studies Cerebral Hemorrhage / cerebrospinal fluid*, complications, psychology Cognition Disorders / cerebrospinal fluid*, complications, psychology Female Humans Male Microcirculation Retrospective Studies |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Overground Physical Therapy Gait Training for Chronic Stroke Patients With Mobility Deficits.
Next Document: Prophylactic, Endovascularly Based, Long-Term Normothermia in ICU Patients With Severe Cerebrovascul...